Conditions: Colorectal Cancer
Keywords: Colorectal Neoplasms Colorectal Tumors Colorectal Carcinoma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 9
Healthy volunteers: no

Brief summary:
The purpose of this trial is to determine the safety and efficacy of Zalutumumab alone or in combination with Irinotecan for the treatment of patients with Colorectal Cancer

Detailed description:

Arms:
arm 1: Zalutumumab in combination with Irinotecan arm 2: Zalutumumab in combination with Irinotecan

Interventions: intervention 1: Zalutumumab
Intervention descriptions: intervention 1: Solution for infusion

Protocol document: